nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefdinir—Enterocolitis haemorrhagic—Vinblastine—head and neck cancer	0.165	0.168	CcSEcCtD
Cefdinir—Diarrhoea haemorrhagic—Docetaxel—head and neck cancer	0.0326	0.033	CcSEcCtD
Cefdinir—Enterocolitis—Docetaxel—head and neck cancer	0.0296	0.03	CcSEcCtD
Cefdinir—Peptic ulcer—Vinblastine—head and neck cancer	0.026	0.0263	CcSEcCtD
Cefdinir—Ileus—Vinblastine—head and neck cancer	0.0245	0.0248	CcSEcCtD
Cefdinir—Digestion impaired—Hydroxyurea—head and neck cancer	0.0237	0.024	CcSEcCtD
Cefdinir—Disseminated intravascular coagulation—Docetaxel—head and neck cancer	0.023	0.0233	CcSEcCtD
Cefdinir—Interstitial pneumonia—Docetaxel—head and neck cancer	0.017	0.0172	CcSEcCtD
Cefdinir—Rash maculo-papular—Hydroxyurea—head and neck cancer	0.0144	0.0146	CcSEcCtD
Cefdinir—Hepatic failure—Hydroxyurea—head and neck cancer	0.0128	0.0129	CcSEcCtD
Cefdinir—Renal failure acute—Hydroxyurea—head and neck cancer	0.0124	0.0126	CcSEcCtD
Cefdinir—Ileus—Docetaxel—head and neck cancer	0.0116	0.0118	CcSEcCtD
Cefdinir—Interstitial lung disease—Docetaxel—head and neck cancer	0.0116	0.0118	CcSEcCtD
Cefdinir—Rash maculo-papular—Fluorouracil—head and neck cancer	0.0104	0.0105	CcSEcCtD
Cefdinir—Pancytopenia—Vinblastine—head and neck cancer	0.0103	0.0105	CcSEcCtD
Cefdinir—Acute coronary syndrome—Vinblastine—head and neck cancer	0.00957	0.00969	CcSEcCtD
Cefdinir—Myocardial infarction—Vinblastine—head and neck cancer	0.00952	0.00964	CcSEcCtD
Cefdinir—Pancytopenia—Hydroxyurea—head and neck cancer	0.00943	0.00955	CcSEcCtD
Cefdinir—Neutropenia—Hydroxyurea—head and neck cancer	0.00929	0.0094	CcSEcCtD
Cefdinir—Agranulocytosis—Vinblastine—head and neck cancer	0.00906	0.00918	CcSEcCtD
Cefdinir—Haemoglobin—Vinblastine—head and neck cancer	0.00876	0.00887	CcSEcCtD
Cefdinir—Haemorrhage—Vinblastine—head and neck cancer	0.00872	0.00883	CcSEcCtD
Cefdinir—Stomatitis—Hydroxyurea—head and neck cancer	0.00863	0.00874	CcSEcCtD
Cefdinir—Cardiac failure—Fluorouracil—head and neck cancer	0.00848	0.00858	CcSEcCtD
Cefdinir—Haemoglobin—Hydroxyurea—head and neck cancer	0.00799	0.00809	CcSEcCtD
Cefdinir—Haemorrhage—Hydroxyurea—head and neck cancer	0.00795	0.00805	CcSEcCtD
Cefdinir—Candida infection—Docetaxel—head and neck cancer	0.00785	0.00795	CcSEcCtD
Cefdinir—Leukopenia—Vinblastine—head and neck cancer	0.00679	0.00688	CcSEcCtD
Cefdinir—Pancytopenia—Fluorouracil—head and neck cancer	0.00679	0.00687	CcSEcCtD
Cefdinir—Hepatic failure—Docetaxel—head and neck cancer	0.00664	0.00673	CcSEcCtD
Cefdinir—Convulsion—Vinblastine—head and neck cancer	0.00657	0.00666	CcSEcCtD
Cefdinir—Hypertension—Vinblastine—head and neck cancer	0.00655	0.00663	CcSEcCtD
Cefdinir—Pneumonia—Fluorouracil—head and neck cancer	0.00641	0.00649	CcSEcCtD
Cefdinir—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.00628	0.00636	CcSEcCtD
Cefdinir—Renal impairment—Docetaxel—head and neck cancer	0.00627	0.00635	CcSEcCtD
Cefdinir—Myocardial infarction—Fluorouracil—head and neck cancer	0.00625	0.00633	CcSEcCtD
Cefdinir—Stomatitis—Fluorouracil—head and neck cancer	0.00621	0.00629	CcSEcCtD
Cefdinir—Conjunctivitis—Fluorouracil—head and neck cancer	0.0062	0.00627	CcSEcCtD
Cefdinir—Leukopenia—Hydroxyurea—head and neck cancer	0.00619	0.00627	CcSEcCtD
Cefdinir—Cardiac failure—Docetaxel—head and neck cancer	0.00612	0.00619	CcSEcCtD
Cefdinir—Thrombocytopenia—Vinblastine—head and neck cancer	0.00606	0.00614	CcSEcCtD
Cefdinir—Convulsion—Hydroxyurea—head and neck cancer	0.006	0.00607	CcSEcCtD
Cefdinir—Agranulocytosis—Fluorouracil—head and neck cancer	0.00595	0.00602	CcSEcCtD
Cefdinir—Anorexia—Vinblastine—head and neck cancer	0.0059	0.00598	CcSEcCtD
Cefdinir—Haemoglobin—Fluorouracil—head and neck cancer	0.00575	0.00582	CcSEcCtD
Cefdinir—Haemorrhage—Fluorouracil—head and neck cancer	0.00572	0.00579	CcSEcCtD
Cefdinir—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.00553	0.0056	CcSEcCtD
Cefdinir—Anorexia—Hydroxyurea—head and neck cancer	0.00538	0.00545	CcSEcCtD
Cefdinir—Decreased appetite—Vinblastine—head and neck cancer	0.00538	0.00545	CcSEcCtD
Cefdinir—Toxic epidermal necrolysis—Docetaxel—head and neck cancer	0.00538	0.00544	CcSEcCtD
Cefdinir—Aspartate aminotransferase increased—Docetaxel—head and neck cancer	0.00538	0.00544	CcSEcCtD
Cefdinir—Constipation—Vinblastine—head and neck cancer	0.0053	0.00536	CcSEcCtD
Cefdinir—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00506	0.00513	CcSEcCtD
Cefdinir—Somnolence—Hydroxyurea—head and neck cancer	0.00502	0.00508	CcSEcCtD
Cefdinir—Dyspepsia—Hydroxyurea—head and neck cancer	0.00497	0.00503	CcSEcCtD
Cefdinir—Decreased appetite—Hydroxyurea—head and neck cancer	0.00491	0.00497	CcSEcCtD
Cefdinir—Pancytopenia—Docetaxel—head and neck cancer	0.0049	0.00496	CcSEcCtD
Cefdinir—Abdominal pain—Vinblastine—head and neck cancer	0.0049	0.00496	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00488	0.00494	CcSEcCtD
Cefdinir—Constipation—Hydroxyurea—head and neck cancer	0.00483	0.00489	CcSEcCtD
Cefdinir—Neutropenia—Docetaxel—head and neck cancer	0.00482	0.00489	CcSEcCtD
Cefdinir—Pneumonia—Docetaxel—head and neck cancer	0.00463	0.00469	CcSEcCtD
Cefdinir—Hypersensitivity—Vinblastine—head and neck cancer	0.00456	0.00462	CcSEcCtD
Cefdinir—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	0.00456	0.00462	CcSEcCtD
Cefdinir—Acute coronary syndrome—Docetaxel—head and neck cancer	0.00454	0.00459	CcSEcCtD
Cefdinir—Renal failure—Docetaxel—head and neck cancer	0.00452	0.00458	CcSEcCtD
Cefdinir—Myocardial infarction—Docetaxel—head and neck cancer	0.00451	0.00457	CcSEcCtD
Cefdinir—Stomatitis—Docetaxel—head and neck cancer	0.00448	0.00454	CcSEcCtD
Cefdinir—Jaundice—Docetaxel—head and neck cancer	0.00448	0.00454	CcSEcCtD
Cefdinir—Conjunctivitis—Docetaxel—head and neck cancer	0.00447	0.00453	CcSEcCtD
Cefdinir—Body temperature increased—Hydroxyurea—head and neck cancer	0.00446	0.00452	CcSEcCtD
Cefdinir—Leukopenia—Fluorouracil—head and neck cancer	0.00446	0.00451	CcSEcCtD
Cefdinir—Asthenia—Vinblastine—head and neck cancer	0.00444	0.0045	CcSEcCtD
Cefdinir—Convulsion—Fluorouracil—head and neck cancer	0.00432	0.00437	CcSEcCtD
Cefdinir—Agranulocytosis—Docetaxel—head and neck cancer	0.00429	0.00435	CcSEcCtD
Cefdinir—Chest pain—Fluorouracil—head and neck cancer	0.00424	0.00429	CcSEcCtD
Cefdinir—Diarrhoea—Vinblastine—head and neck cancer	0.00424	0.00429	CcSEcCtD
Cefdinir—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00416	0.00421	CcSEcCtD
Cefdinir—Haemoglobin—Docetaxel—head and neck cancer	0.00415	0.0042	CcSEcCtD
Cefdinir—Haemorrhage—Docetaxel—head and neck cancer	0.00413	0.00418	CcSEcCtD
Cefdinir—Dizziness—Vinblastine—head and neck cancer	0.0041	0.00415	CcSEcCtD
Cefdinir—Anaphylactic shock—Fluorouracil—head and neck cancer	0.00407	0.00412	CcSEcCtD
Cefdinir—Asthenia—Hydroxyurea—head and neck cancer	0.00405	0.0041	CcSEcCtD
Cefdinir—Thrombocytopenia—Fluorouracil—head and neck cancer	0.00398	0.00403	CcSEcCtD
Cefdinir—Vomiting—Vinblastine—head and neck cancer	0.00394	0.00399	CcSEcCtD
Cefdinir—Erythema multiforme—Docetaxel—head and neck cancer	0.0039	0.00395	CcSEcCtD
Cefdinir—Headache—Vinblastine—head and neck cancer	0.00388	0.00393	CcSEcCtD
Cefdinir—Anorexia—Fluorouracil—head and neck cancer	0.00388	0.00392	CcSEcCtD
Cefdinir—Diarrhoea—Hydroxyurea—head and neck cancer	0.00386	0.00391	CcSEcCtD
Cefdinir—Dizziness—Hydroxyurea—head and neck cancer	0.00373	0.00378	CcSEcCtD
Cefdinir—Nausea—Vinblastine—head and neck cancer	0.00368	0.00372	CcSEcCtD
Cefdinir—Insomnia—Fluorouracil—head and neck cancer	0.00368	0.00372	CcSEcCtD
Cefdinir—Somnolence—Fluorouracil—head and neck cancer	0.00361	0.00366	CcSEcCtD
Cefdinir—Vomiting—Hydroxyurea—head and neck cancer	0.00359	0.00364	CcSEcCtD
Cefdinir—Dyspepsia—Fluorouracil—head and neck cancer	0.00358	0.00362	CcSEcCtD
Cefdinir—Rash—Hydroxyurea—head and neck cancer	0.00356	0.00361	CcSEcCtD
Cefdinir—Dermatitis—Hydroxyurea—head and neck cancer	0.00356	0.0036	CcSEcCtD
Cefdinir—Headache—Hydroxyurea—head and neck cancer	0.00354	0.00358	CcSEcCtD
Cefdinir—Decreased appetite—Fluorouracil—head and neck cancer	0.00353	0.00358	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.00351	0.00355	CcSEcCtD
Cefdinir—MPO—saliva—head and neck cancer	0.00336	0.27	CbGeAlD
Cefdinir—Nausea—Hydroxyurea—head and neck cancer	0.00335	0.0034	CcSEcCtD
Cefdinir—Leukopenia—Docetaxel—head and neck cancer	0.00322	0.00326	CcSEcCtD
Cefdinir—Body temperature increased—Fluorouracil—head and neck cancer	0.00321	0.00325	CcSEcCtD
Cefdinir—Loss of consciousness—Docetaxel—head and neck cancer	0.00316	0.0032	CcSEcCtD
Cefdinir—Convulsion—Docetaxel—head and neck cancer	0.00312	0.00315	CcSEcCtD
Cefdinir—Hypertension—Docetaxel—head and neck cancer	0.0031	0.00314	CcSEcCtD
Cefdinir—Chest pain—Docetaxel—head and neck cancer	0.00306	0.0031	CcSEcCtD
Cefdinir—Hypersensitivity—Fluorouracil—head and neck cancer	0.003	0.00303	CcSEcCtD
Cefdinir—Dry mouth—Docetaxel—head and neck cancer	0.00299	0.00303	CcSEcCtD
Cefdinir—Anaphylactic shock—Docetaxel—head and neck cancer	0.00293	0.00297	CcSEcCtD
Cefdinir—Shock—Docetaxel—head and neck cancer	0.00289	0.00292	CcSEcCtD
Cefdinir—Pruritus—Fluorouracil—head and neck cancer	0.00288	0.00291	CcSEcCtD
Cefdinir—Thrombocytopenia—Docetaxel—head and neck cancer	0.00287	0.00291	CcSEcCtD
Cefdinir—Anorexia—Docetaxel—head and neck cancer	0.0028	0.00283	CcSEcCtD
Cefdinir—Diarrhoea—Fluorouracil—head and neck cancer	0.00278	0.00282	CcSEcCtD
Cefdinir—Dizziness—Fluorouracil—head and neck cancer	0.00269	0.00272	CcSEcCtD
Cefdinir—Insomnia—Docetaxel—head and neck cancer	0.00265	0.00269	CcSEcCtD
Cefdinir—Somnolence—Docetaxel—head and neck cancer	0.00261	0.00264	CcSEcCtD
Cefdinir—Vomiting—Fluorouracil—head and neck cancer	0.00258	0.00262	CcSEcCtD
Cefdinir—Dyspepsia—Docetaxel—head and neck cancer	0.00258	0.00262	CcSEcCtD
Cefdinir—Rash—Fluorouracil—head and neck cancer	0.00256	0.0026	CcSEcCtD
Cefdinir—Dermatitis—Fluorouracil—head and neck cancer	0.00256	0.00259	CcSEcCtD
Cefdinir—Decreased appetite—Docetaxel—head and neck cancer	0.00255	0.00258	CcSEcCtD
Cefdinir—Headache—Fluorouracil—head and neck cancer	0.00255	0.00258	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.00253	0.00257	CcSEcCtD
Cefdinir—Constipation—Docetaxel—head and neck cancer	0.00251	0.00254	CcSEcCtD
Cefdinir—Nausea—Fluorouracil—head and neck cancer	0.00241	0.00245	CcSEcCtD
Cefdinir—Gastrointestinal pain—Docetaxel—head and neck cancer	0.0024	0.00243	CcSEcCtD
Cefdinir—Body temperature increased—Docetaxel—head and neck cancer	0.00232	0.00235	CcSEcCtD
Cefdinir—Abdominal pain—Docetaxel—head and neck cancer	0.00232	0.00235	CcSEcCtD
Cefdinir—Hypersensitivity—Docetaxel—head and neck cancer	0.00216	0.00219	CcSEcCtD
Cefdinir—Asthenia—Docetaxel—head and neck cancer	0.00211	0.00213	CcSEcCtD
Cefdinir—Pruritus—Docetaxel—head and neck cancer	0.00208	0.0021	CcSEcCtD
Cefdinir—Diarrhoea—Docetaxel—head and neck cancer	0.00201	0.00203	CcSEcCtD
Cefdinir—Dizziness—Docetaxel—head and neck cancer	0.00194	0.00196	CcSEcCtD
Cefdinir—Vomiting—Docetaxel—head and neck cancer	0.00187	0.00189	CcSEcCtD
Cefdinir—Rash—Docetaxel—head and neck cancer	0.00185	0.00187	CcSEcCtD
Cefdinir—Dermatitis—Docetaxel—head and neck cancer	0.00185	0.00187	CcSEcCtD
Cefdinir—Headache—Docetaxel—head and neck cancer	0.00184	0.00186	CcSEcCtD
Cefdinir—Nausea—Docetaxel—head and neck cancer	0.00174	0.00176	CcSEcCtD
Cefdinir—SLC15A2—mouth—head and neck cancer	0.000883	0.071	CbGeAlD
Cefdinir—SLC15A1—epithelium—head and neck cancer	0.000821	0.0661	CbGeAlD
Cefdinir—MPO—connective tissue—head and neck cancer	0.000778	0.0626	CbGeAlD
Cefdinir—MPO—epithelium—head and neck cancer	0.000739	0.0594	CbGeAlD
Cefdinir—SLC15A2—parotid gland—head and neck cancer	0.000614	0.0494	CbGeAlD
Cefdinir—SLC15A2—saliva-secreting gland—head and neck cancer	0.000589	0.0473	CbGeAlD
Cefdinir—MPO—lymphoid tissue—head and neck cancer	0.000569	0.0458	CbGeAlD
Cefdinir—SLC22A5—parotid gland—head and neck cancer	0.000534	0.043	CbGeAlD
Cefdinir—SLC22A5—saliva-secreting gland—head and neck cancer	0.000512	0.0412	CbGeAlD
Cefdinir—MPO—head—head and neck cancer	0.000459	0.0369	CbGeAlD
Cefdinir—SLC15A2—trachea—head and neck cancer	0.000454	0.0365	CbGeAlD
Cefdinir—SLC22A5—trachea—head and neck cancer	0.000395	0.0318	CbGeAlD
Cefdinir—SLC15A2—thyroid gland—head and neck cancer	0.000359	0.0289	CbGeAlD
Cefdinir—MPO—lymph node—head and neck cancer	0.000321	0.0258	CbGeAlD
Cefdinir—SLC15A2—head—head and neck cancer	0.000319	0.0256	CbGeAlD
Cefdinir—SLC22A5—thyroid gland—head and neck cancer	0.000312	0.0251	CbGeAlD
Cefdinir—SLC15A2—lymph node—head and neck cancer	0.000223	0.0179	CbGeAlD
Cefdinir—SLC22A5—lymph node—head and neck cancer	0.000194	0.0156	CbGeAlD
